ADDYI (Sprout Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the ADDYI drug offered from Sprout Pharmaceuticals, Inc.. This P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sprout Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | flibanserin |
| SUBSTANCE NAME: | FLIBANSERIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-08-18 |
| END MARKETING DATE: | 0000-00-00 |
ADDYI HUMAN PRESCRIPTION DRUG Details:
| Item Description | ADDYI from Sprout Pharmaceuticals, Inc. |
| LABELER NAME: | Sprout Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2015-08-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58604-214_5a8145a5-061f-46aa-bb48-a282b91b627a |
| PRODUCT NDC: | 58604-214 |
| APPLICATION NUMBER: | NDA022526 |
Other FLIBANSERIN Pharmaceutical Manufacturers / Labelers:
